ID4 (inhibitor of differentiation 4) is a dominant negative regulator of the basic helix-loop-helix transcription factors associated with breast cancer aggressiveness, particularly with the basal-like subtype of triple-negative breast cancer (TNBC), where it associates with reduced survival and acts as an independent prognostic factor [18]. Here, ID4 is linked to breast cancer.